| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intermittent Claudication | 32 | 2021 | 304 | 5.890 |
Why?
|
| Cost-Benefit Analysis | 93 | 2023 | 5494 | 3.320 |
Why?
|
| Decision Support Techniques | 35 | 2020 | 2000 | 2.940 |
Why?
|
| Peripheral Vascular Diseases | 23 | 2009 | 488 | 2.730 |
Why?
|
| Exercise Therapy | 15 | 2021 | 922 | 2.330 |
Why?
|
| Markov Chains | 33 | 2022 | 965 | 2.250 |
Why?
|
| Angiography, Digital Subtraction | 21 | 2014 | 335 | 2.210 |
Why?
|
| Quality-Adjusted Life Years | 44 | 2022 | 1723 | 2.170 |
Why?
|
| Tomography, X-Ray Computed | 66 | 2022 | 20600 | 2.090 |
Why?
|
| Magnetic Resonance Angiography | 23 | 2013 | 1432 | 1.970 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 2 | 2024 | 49 | 1.700 |
Why?
|
| Vascular Surgical Procedures | 13 | 2018 | 1489 | 1.580 |
Why?
|
| Craniocerebral Trauma | 9 | 2022 | 490 | 1.550 |
Why?
|
| Angioplasty, Balloon | 16 | 2013 | 589 | 1.530 |
Why?
|
| Diagnostic Imaging | 15 | 2023 | 3535 | 1.470 |
Why?
|
| Quality of Life | 47 | 2022 | 13362 | 1.440 |
Why?
|
| Coronary Artery Disease | 25 | 2022 | 6504 | 1.400 |
Why?
|
| Coronary Angiography | 21 | 2017 | 4506 | 1.400 |
Why?
|
| Knee Injuries | 10 | 2011 | 488 | 1.240 |
Why?
|
| Ultrasonography, Doppler, Duplex | 11 | 2015 | 198 | 1.200 |
Why?
|
| Cardiovascular Diseases | 30 | 2024 | 15513 | 1.150 |
Why?
|
| Autopsy | 8 | 2020 | 1010 | 1.150 |
Why?
|
| Uncertainty | 7 | 2024 | 752 | 1.090 |
Why?
|
| Arterial Occlusive Diseases | 12 | 2005 | 749 | 1.080 |
Why?
|
| Adenoma | 4 | 2024 | 2159 | 1.070 |
Why?
|
| Netherlands | 31 | 2021 | 2222 | 1.070 |
Why?
|
| Chest Pain | 7 | 2016 | 1095 | 1.040 |
Why?
|
| Angiography | 12 | 2015 | 1597 | 1.030 |
Why?
|
| Pituitary Neoplasms | 3 | 2023 | 1323 | 1.020 |
Why?
|
| Health Care Costs | 19 | 2021 | 3238 | 1.000 |
Why?
|
| Asymptomatic Diseases | 4 | 2013 | 588 | 0.950 |
Why?
|
| Randomized Controlled Trials as Topic | 18 | 2023 | 10213 | 0.940 |
Why?
|
| Yoga | 3 | 2018 | 281 | 0.940 |
Why?
|
| Coronary Disease | 26 | 2020 | 5921 | 0.940 |
Why?
|
| Meditation | 2 | 2018 | 251 | 0.930 |
Why?
|
| Decision Making | 14 | 2024 | 3925 | 0.910 |
Why?
|
| Programming Languages | 3 | 2022 | 129 | 0.870 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2017 | 278 | 0.840 |
Why?
|
| Music Therapy | 4 | 2018 | 111 | 0.840 |
Why?
|
| Humans | 320 | 2024 | 761098 | 0.810 |
Why?
|
| Primary Prevention | 8 | 2018 | 1185 | 0.790 |
Why?
|
| Iliac Artery | 8 | 2000 | 343 | 0.780 |
Why?
|
| Mind-Body Therapies | 2 | 2015 | 280 | 0.770 |
Why?
|
| Carotid Stenosis | 8 | 2011 | 859 | 0.770 |
Why?
|
| Sensitivity and Specificity | 47 | 2018 | 14676 | 0.750 |
Why?
|
| Monte Carlo Method | 13 | 2016 | 1257 | 0.740 |
Why?
|
| Acupuncture Therapy | 3 | 2010 | 486 | 0.720 |
Why?
|
| Brain Ischemia | 8 | 2021 | 3031 | 0.720 |
Why?
|
| Decision Support Systems, Clinical | 4 | 2023 | 1171 | 0.710 |
Why?
|
| ROC Curve | 26 | 2018 | 3582 | 0.700 |
Why?
|
| Practice Guidelines as Topic | 10 | 2020 | 7400 | 0.690 |
Why?
|
| Myocardial Perfusion Imaging | 4 | 2013 | 659 | 0.670 |
Why?
|
| Magnetic Resonance Imaging | 34 | 2020 | 36418 | 0.650 |
Why?
|
| Stents | 13 | 2013 | 3177 | 0.650 |
Why?
|
| Stroke | 16 | 2024 | 9720 | 0.650 |
Why?
|
| Breech Presentation | 2 | 2010 | 39 | 0.640 |
Why?
|
| Computer Simulation | 18 | 2022 | 6225 | 0.640 |
Why?
|
| Exercise Test | 13 | 2015 | 2165 | 0.630 |
Why?
|
| Walking | 9 | 2020 | 1194 | 0.630 |
Why?
|
| Leg | 12 | 2011 | 1087 | 0.620 |
Why?
|
| Popliteal Artery | 8 | 2013 | 310 | 0.620 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 94 | 0.610 |
Why?
|
| Middle Aged | 149 | 2021 | 220835 | 0.600 |
Why?
|
| Renal Artery Obstruction | 4 | 2007 | 218 | 0.600 |
Why?
|
| Models, Statistical | 17 | 2020 | 5077 | 0.600 |
Why?
|
| Musculoskeletal Diseases | 2 | 2017 | 597 | 0.600 |
Why?
|
| Risk Reduction Behavior | 4 | 2019 | 1111 | 0.590 |
Why?
|
| Aged | 134 | 2021 | 169266 | 0.590 |
Why?
|
| Ultrasonography, Doppler, Color | 4 | 2003 | 232 | 0.570 |
Why?
|
| Renal Replacement Therapy | 2 | 2011 | 281 | 0.570 |
Why?
|
| Drug Approval | 1 | 2024 | 812 | 0.560 |
Why?
|
| Lymphoma, Follicular | 1 | 2021 | 457 | 0.560 |
Why?
|
| Male | 171 | 2021 | 360675 | 0.560 |
Why?
|
| Glasgow Coma Scale | 8 | 2022 | 579 | 0.550 |
Why?
|
| Evidence-Based Medicine | 8 | 2020 | 3689 | 0.540 |
Why?
|
| Living Donors | 4 | 2011 | 643 | 0.540 |
Why?
|
| Female | 171 | 2020 | 392458 | 0.540 |
Why?
|
| Predictive Value of Tests | 36 | 2017 | 15308 | 0.530 |
Why?
|
| Resilience, Psychological | 1 | 2023 | 788 | 0.500 |
Why?
|
| Risk Assessment | 35 | 2022 | 24013 | 0.490 |
Why?
|
| Hyperthermia, Induced | 1 | 2019 | 417 | 0.490 |
Why?
|
| Models, Economic | 9 | 2020 | 714 | 0.490 |
Why?
|
| Life Style | 4 | 2019 | 3908 | 0.480 |
Why?
|
| Patient Selection | 14 | 2018 | 4245 | 0.470 |
Why?
|
| Peripheral Arterial Disease | 5 | 2015 | 1274 | 0.470 |
Why?
|
| Ischemic Attack, Transient | 4 | 2011 | 874 | 0.470 |
Why?
|
| Occupational Health Services | 1 | 2015 | 150 | 0.460 |
Why?
|
| Guidelines as Topic | 2 | 2019 | 1386 | 0.460 |
Why?
|
| Chi-Square Distribution | 13 | 2015 | 3419 | 0.450 |
Why?
|
| Femoral Artery | 7 | 2004 | 826 | 0.450 |
Why?
|
| Aortic Aneurysm, Abdominal | 8 | 2013 | 1228 | 0.450 |
Why?
|
| Endovascular Procedures | 10 | 2019 | 2181 | 0.440 |
Why?
|
| Health Status | 10 | 2018 | 4077 | 0.440 |
Why?
|
| Decision Trees | 11 | 2021 | 505 | 0.430 |
Why?
|
| Costs and Cost Analysis | 12 | 2012 | 1664 | 0.430 |
Why?
|
| Attitude to Health | 6 | 2000 | 2024 | 0.430 |
Why?
|
| Treatment Outcome | 48 | 2021 | 64670 | 0.420 |
Why?
|
| Technology Assessment, Biomedical | 3 | 2021 | 306 | 0.420 |
Why?
|
| Risk Factors | 63 | 2023 | 74219 | 0.420 |
Why?
|
| Calcium | 6 | 2022 | 5720 | 0.420 |
Why?
|
| Gynecological Examination | 1 | 2013 | 30 | 0.420 |
Why?
|
| Mass Screening | 7 | 2016 | 5425 | 0.420 |
Why?
|
| Echocardiography, Stress | 4 | 2011 | 135 | 0.420 |
Why?
|
| Brain Injuries | 6 | 2019 | 2054 | 0.410 |
Why?
|
| Wrist Injuries | 2 | 2005 | 214 | 0.410 |
Why?
|
| Natural Language Processing | 2 | 2019 | 1166 | 0.410 |
Why?
|
| Perfusion Imaging | 1 | 2014 | 198 | 0.410 |
Why?
|
| Ischemia | 10 | 2017 | 1889 | 0.410 |
Why?
|
| Coronary Stenosis | 6 | 2017 | 802 | 0.410 |
Why?
|
| Peritoneal Neoplasms | 1 | 2019 | 710 | 0.400 |
Why?
|
| Cerebral Angiography | 3 | 2014 | 1281 | 0.400 |
Why?
|
| Life Expectancy | 6 | 2014 | 1242 | 0.400 |
Why?
|
| Radiology | 9 | 2018 | 2114 | 0.400 |
Why?
|
| Endarterectomy, Carotid | 5 | 2011 | 554 | 0.400 |
Why?
|
| Aged, 80 and over | 58 | 2022 | 58946 | 0.390 |
Why?
|
| Radiography | 10 | 2023 | 6975 | 0.390 |
Why?
|
| Stress, Psychological | 8 | 2023 | 4488 | 0.390 |
Why?
|
| Calcinosis | 7 | 2011 | 1477 | 0.390 |
Why?
|
| Vasospasm, Intracranial | 1 | 2014 | 214 | 0.390 |
Why?
|
| Prospective Studies | 47 | 2022 | 54419 | 0.380 |
Why?
|
| Kidney Transplantation | 6 | 2011 | 4240 | 0.380 |
Why?
|
| Angioplasty | 4 | 2014 | 356 | 0.380 |
Why?
|
| Ankle Injuries | 3 | 2006 | 338 | 0.370 |
Why?
|
| Coronary Vessels | 5 | 2022 | 3111 | 0.370 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2014 | 279 | 0.360 |
Why?
|
| Emergency Service, Hospital | 5 | 2021 | 7873 | 0.360 |
Why?
|
| Amygdala | 1 | 2018 | 1354 | 0.360 |
Why?
|
| Carotid Artery Diseases | 5 | 2011 | 877 | 0.360 |
Why?
|
| Aortic Rupture | 5 | 2011 | 319 | 0.360 |
Why?
|
| Hospital Costs | 5 | 2013 | 947 | 0.360 |
Why?
|
| Adult | 90 | 2024 | 221083 | 0.350 |
Why?
|
| Angina Pectoris | 3 | 2011 | 959 | 0.350 |
Why?
|
| Logistic Models | 18 | 2017 | 13254 | 0.350 |
Why?
|
| Cause of Death | 10 | 2020 | 3688 | 0.340 |
Why?
|
| Health Status Indicators | 5 | 2000 | 970 | 0.340 |
Why?
|
| Regression Analysis | 17 | 2016 | 6343 | 0.340 |
Why?
|
| Statistics, Nonparametric | 8 | 2013 | 2855 | 0.340 |
Why?
|
| Family Practice | 2 | 2009 | 507 | 0.330 |
Why?
|
| Reflex Sympathetic Dystrophy | 1 | 2009 | 58 | 0.330 |
Why?
|
| Reproducibility of Results | 28 | 2019 | 20120 | 0.330 |
Why?
|
| Peritoneal Dialysis | 2 | 2007 | 159 | 0.330 |
Why?
|
| Mastectomy | 1 | 2017 | 1817 | 0.330 |
Why?
|
| Models, Theoretical | 8 | 2017 | 3568 | 0.320 |
Why?
|
| Pain Measurement | 4 | 2018 | 3548 | 0.320 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2014 | 1033 | 0.320 |
Why?
|
| Mobility Limitation | 2 | 2011 | 408 | 0.320 |
Why?
|
| Contrast Media | 13 | 2018 | 5311 | 0.320 |
Why?
|
| Ankle Brachial Index | 4 | 2014 | 163 | 0.310 |
Why?
|
| Physical Endurance | 1 | 2011 | 366 | 0.310 |
Why?
|
| Meta-Analysis as Topic | 6 | 2023 | 1381 | 0.310 |
Why?
|
| Hypercholesterolemia | 4 | 2012 | 1141 | 0.310 |
Why?
|
| Menstruation Disturbances | 1 | 2009 | 143 | 0.310 |
Why?
|
| Aortic Diseases | 5 | 2011 | 735 | 0.300 |
Why?
|
| Secondary Prevention | 1 | 2014 | 1472 | 0.300 |
Why?
|
| Otolaryngology | 3 | 2020 | 693 | 0.300 |
Why?
|
| Mammaplasty | 1 | 2017 | 1232 | 0.290 |
Why?
|
| Triglycerides | 1 | 2015 | 2457 | 0.290 |
Why?
|
| Head Injuries, Closed | 3 | 2019 | 133 | 0.280 |
Why?
|
| Kidney Failure, Chronic | 3 | 2011 | 2478 | 0.280 |
Why?
|
| Severity of Illness Index | 19 | 2019 | 15845 | 0.280 |
Why?
|
| Sex Factors | 17 | 2018 | 10552 | 0.280 |
Why?
|
| Aneurysm | 3 | 2015 | 337 | 0.280 |
Why?
|
| Health Promotion | 2 | 2018 | 2205 | 0.280 |
Why?
|
| Blood Vessel Prosthesis Implantation | 5 | 2015 | 1425 | 0.280 |
Why?
|
| Vascular Patency | 9 | 2014 | 911 | 0.280 |
Why?
|
| Software | 6 | 2022 | 4433 | 0.280 |
Why?
|
| Thrombectomy | 3 | 2021 | 702 | 0.280 |
Why?
|
| Follow-Up Studies | 24 | 2021 | 39121 | 0.280 |
Why?
|
| Blood Platelet Disorders | 1 | 2007 | 60 | 0.270 |
Why?
|
| Time Factors | 29 | 2021 | 39953 | 0.270 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2020 | 3245 | 0.270 |
Why?
|
| Biopsy | 3 | 2015 | 6781 | 0.270 |
Why?
|
| Prognosis | 18 | 2019 | 29672 | 0.270 |
Why?
|
| Prostate | 1 | 2014 | 1772 | 0.270 |
Why?
|
| Heart Diseases | 3 | 2015 | 2795 | 0.260 |
Why?
|
| Menstrual Cycle | 1 | 2009 | 539 | 0.260 |
Why?
|
| Amaurosis Fugax | 1 | 2005 | 7 | 0.260 |
Why?
|
| Myocardial Ischemia | 3 | 2018 | 2133 | 0.260 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2007 | 806 | 0.250 |
Why?
|
| Recovery of Function | 8 | 2014 | 2981 | 0.250 |
Why?
|
| Defibrillators, Implantable | 2 | 2012 | 1492 | 0.250 |
Why?
|
| Platelet Function Tests | 1 | 2007 | 271 | 0.250 |
Why?
|
| Algorithms | 8 | 2019 | 14023 | 0.250 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2018 | 2020 | 0.240 |
Why?
|
| Probability | 8 | 2022 | 2478 | 0.240 |
Why?
|
| Cohort Studies | 20 | 2022 | 41486 | 0.240 |
Why?
|
| Radiosurgery | 1 | 2014 | 1339 | 0.240 |
Why?
|
| Resource Allocation | 2 | 2018 | 350 | 0.240 |
Why?
|
| Patient Satisfaction | 2 | 2010 | 3450 | 0.240 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2012 | 1559 | 0.240 |
Why?
|
| Splenic Artery | 2 | 2015 | 58 | 0.240 |
Why?
|
| Specialties, Surgical | 1 | 2009 | 389 | 0.230 |
Why?
|
| Body Mass Index | 6 | 2015 | 12951 | 0.230 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 6 | 2016 | 1130 | 0.230 |
Why?
|
| Colorectal Neoplasms | 5 | 2019 | 6919 | 0.230 |
Why?
|
| Multicenter Studies as Topic | 2 | 2023 | 1702 | 0.220 |
Why?
|
| Gadolinium DTPA | 3 | 2018 | 823 | 0.220 |
Why?
|
| Forecasting | 1 | 2012 | 2928 | 0.220 |
Why?
|
| Blood Glucose | 2 | 2015 | 6390 | 0.220 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 5333 | 0.220 |
Why?
|
| Lactotrophs | 1 | 2022 | 3 | 0.210 |
Why?
|
| Somatotrophs | 1 | 2022 | 2 | 0.210 |
Why?
|
| Kidney | 5 | 2017 | 7034 | 0.210 |
Why?
|
| Cost of Illness | 5 | 2012 | 1937 | 0.210 |
Why?
|
| Atherosclerosis | 5 | 2022 | 3405 | 0.200 |
Why?
|
| Amnesia | 2 | 2019 | 255 | 0.200 |
Why?
|
| Diabetes Mellitus | 5 | 2023 | 5841 | 0.200 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2012 | 1554 | 0.200 |
Why?
|
| Comparative Effectiveness Research | 4 | 2016 | 709 | 0.200 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 1400 | 0.190 |
Why?
|
| Octreotide | 1 | 2022 | 154 | 0.190 |
Why?
|
| Combined Modality Therapy | 3 | 2019 | 8519 | 0.190 |
Why?
|
| Genes, BRCA1 | 2 | 2016 | 754 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2014 | 11118 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 2130 | 0.190 |
Why?
|
| Radiology, Interventional | 1 | 2005 | 477 | 0.180 |
Why?
|
| Cost Savings | 5 | 2016 | 912 | 0.180 |
Why?
|
| Proportional Hazards Models | 12 | 2024 | 12467 | 0.180 |
Why?
|
| United States | 28 | 2024 | 72337 | 0.180 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2021 | 385 | 0.180 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 1994 | 290 | 0.180 |
Why?
|
| Prevalence | 13 | 2017 | 15717 | 0.180 |
Why?
|
| Ritonavir | 1 | 2022 | 329 | 0.170 |
Why?
|
| Triage | 2 | 2019 | 984 | 0.170 |
Why?
|
| Selection Bias | 1 | 2002 | 359 | 0.170 |
Why?
|
| Intention | 1 | 2023 | 347 | 0.170 |
Why?
|
| Canada | 2 | 2021 | 2125 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 1 | 2012 | 2018 | 0.170 |
Why?
|
| Mastectomy, Segmental | 2 | 2017 | 955 | 0.170 |
Why?
|
| Confidence Intervals | 5 | 2012 | 2927 | 0.170 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 2191 | 0.170 |
Why?
|
| Research Design | 5 | 2023 | 6178 | 0.170 |
Why?
|
| Abdominal Neoplasms | 1 | 2001 | 287 | 0.170 |
Why?
|
| Odds Ratio | 10 | 2015 | 9648 | 0.170 |
Why?
|
| Lower Extremity | 1 | 2007 | 1201 | 0.160 |
Why?
|
| Positron-Emission Tomography | 4 | 2016 | 6585 | 0.160 |
Why?
|
| Dyslipidemias | 2 | 2017 | 870 | 0.160 |
Why?
|
| Synovitis | 1 | 2020 | 217 | 0.160 |
Why?
|
| Life Tables | 5 | 1998 | 364 | 0.160 |
Why?
|
| Aorta, Thoracic | 6 | 2014 | 1096 | 0.160 |
Why?
|
| Gadolinium | 2 | 2003 | 961 | 0.160 |
Why?
|
| Radiography, Interventional | 4 | 2018 | 1122 | 0.160 |
Why?
|
| Breast Neoplasms | 5 | 2017 | 20981 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2016 | 2746 | 0.160 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2018 | 29 | 0.160 |
Why?
|
| Adenoma, Liver Cell | 1 | 2018 | 32 | 0.160 |
Why?
|
| Hormones | 1 | 2022 | 869 | 0.150 |
Why?
|
| Thoracic Injuries | 2 | 2005 | 288 | 0.150 |
Why?
|
| Arteriosclerosis | 4 | 2008 | 1056 | 0.150 |
Why?
|
| Adolescent | 26 | 2022 | 88271 | 0.150 |
Why?
|
| Meglumine | 1 | 2018 | 144 | 0.150 |
Why?
|
| Creatinine | 3 | 2024 | 1897 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2023 | 1818 | 0.150 |
Why?
|
| Hospital Mortality | 5 | 2018 | 5296 | 0.150 |
Why?
|
| Hydroxychloroquine | 1 | 2022 | 426 | 0.150 |
Why?
|
| Directive Counseling | 1 | 2019 | 170 | 0.150 |
Why?
|
| Nephrectomy | 3 | 2017 | 938 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11732 | 0.150 |
Why?
|
| Vascular Diseases | 3 | 2014 | 1160 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 4 | 2023 | 2691 | 0.150 |
Why?
|
| Endosonography | 2 | 2014 | 608 | 0.150 |
Why?
|
| Age Factors | 13 | 2018 | 18385 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2009 | 1923 | 0.150 |
Why?
|
| Postmortem Changes | 1 | 2017 | 119 | 0.140 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2014 | 695 | 0.140 |
Why?
|
| Survival Analysis | 6 | 2012 | 10083 | 0.140 |
Why?
|
| Myocardial Infarction | 7 | 2018 | 11475 | 0.140 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2020 | 1754 | 0.140 |
Why?
|
| Survival Rate | 6 | 2019 | 12727 | 0.140 |
Why?
|
| Interviews as Topic | 2 | 2010 | 2696 | 0.140 |
Why?
|
| Models, Biological | 2 | 2012 | 9455 | 0.140 |
Why?
|
| Salvage Therapy | 1 | 2024 | 1264 | 0.140 |
Why?
|
| Mammography | 3 | 2017 | 2430 | 0.140 |
Why?
|
| Post-Concussion Syndrome | 2 | 2010 | 243 | 0.140 |
Why?
|
| Organometallic Compounds | 2 | 2018 | 647 | 0.140 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 4308 | 0.140 |
Why?
|
| Internet | 4 | 2019 | 3094 | 0.140 |
Why?
|
| Universities | 1 | 2022 | 995 | 0.140 |
Why?
|
| Anxiety | 3 | 2018 | 4572 | 0.140 |
Why?
|
| Forensic Medicine | 1 | 2017 | 64 | 0.140 |
Why?
|
| Standard of Care | 3 | 2019 | 550 | 0.140 |
Why?
|
| False Positive Reactions | 5 | 2007 | 958 | 0.140 |
Why?
|
| Area Under Curve | 4 | 2018 | 1636 | 0.130 |
Why?
|
| Veins | 1 | 2001 | 767 | 0.130 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2016 | 52 | 0.130 |
Why?
|
| Blood Flow Velocity | 6 | 2013 | 1374 | 0.130 |
Why?
|
| Hypertension | 7 | 2017 | 8537 | 0.130 |
Why?
|
| Wounds and Injuries | 2 | 2008 | 2492 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 2 | 2020 | 1235 | 0.130 |
Why?
|
| Contusions | 2 | 2007 | 79 | 0.130 |
Why?
|
| Catheterization | 1 | 2001 | 1428 | 0.130 |
Why?
|
| Catheter Ablation | 1 | 2009 | 2751 | 0.130 |
Why?
|
| Aorta, Abdominal | 3 | 1997 | 625 | 0.130 |
Why?
|
| Age Distribution | 4 | 2011 | 2873 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 5318 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2024 | 1661 | 0.130 |
Why?
|
| Cardiovascular System | 1 | 2023 | 836 | 0.130 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2016 | 54 | 0.130 |
Why?
|
| Vasodilator Agents | 3 | 2018 | 989 | 0.130 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 14607 | 0.130 |
Why?
|
| Echocardiography | 4 | 2015 | 5006 | 0.130 |
Why?
|
| Observer Variation | 6 | 2018 | 2611 | 0.130 |
Why?
|
| Popliteal Vein | 1 | 1995 | 43 | 0.130 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2017 | 182 | 0.130 |
Why?
|
| Smoking Cessation | 2 | 2018 | 2057 | 0.120 |
Why?
|
| Treatment Failure | 2 | 2009 | 2643 | 0.120 |
Why?
|
| Sick Leave | 1 | 2016 | 105 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2012 | 832 | 0.120 |
Why?
|
| Smoking | 7 | 2017 | 9055 | 0.120 |
Why?
|
| Radiography, Thoracic | 2 | 2019 | 1303 | 0.120 |
Why?
|
| Young Adult | 19 | 2019 | 59199 | 0.120 |
Why?
|
| Liver Cirrhosis | 2 | 2016 | 1932 | 0.120 |
Why?
|
| Tissue Donors | 2 | 2016 | 2334 | 0.120 |
Why?
|
| Hernia, Ventral | 1 | 2019 | 218 | 0.120 |
Why?
|
| Ultrasonography, Mammary | 1 | 2017 | 239 | 0.120 |
Why?
|
| Health Care Rationing | 1 | 1998 | 435 | 0.120 |
Why?
|
| Cholesterol, LDL | 3 | 2015 | 2380 | 0.120 |
Why?
|
| Telephone | 1 | 1998 | 625 | 0.120 |
Why?
|
| Femoral Vein | 1 | 1995 | 153 | 0.120 |
Why?
|
| Ticlopidine | 2 | 2014 | 730 | 0.120 |
Why?
|
| Musculoskeletal System | 1 | 2017 | 188 | 0.120 |
Why?
|
| Watchful Waiting | 1 | 2019 | 489 | 0.120 |
Why?
|
| Dexamethasone | 1 | 2022 | 1945 | 0.120 |
Why?
|
| Retirement | 1 | 2016 | 197 | 0.120 |
Why?
|
| Sweden | 1 | 2017 | 1379 | 0.120 |
Why?
|
| Mental Health | 2 | 2022 | 3251 | 0.120 |
Why?
|
| Intention to Treat Analysis | 1 | 2015 | 413 | 0.120 |
Why?
|
| Unconsciousness | 3 | 2019 | 249 | 0.120 |
Why?
|
| Lung Neoplasms | 3 | 2014 | 13382 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 9278 | 0.120 |
Why?
|
| Nutrition Policy | 1 | 2018 | 466 | 0.120 |
Why?
|
| Europe | 4 | 2016 | 3422 | 0.120 |
Why?
|
| Saphenous Vein | 2 | 2013 | 516 | 0.110 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2015 | 113 | 0.110 |
Why?
|
| Analysis of Variance | 4 | 2008 | 6224 | 0.110 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2016 | 389 | 0.110 |
Why?
|
| Tumor Burden | 2 | 2017 | 1892 | 0.110 |
Why?
|
| Referral and Consultation | 3 | 2016 | 3603 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2007 | 951 | 0.110 |
Why?
|
| Functional Laterality | 2 | 2018 | 2256 | 0.110 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1405 | 0.110 |
Why?
|
| Carotid Arteries | 2 | 2010 | 941 | 0.110 |
Why?
|
| False Negative Reactions | 3 | 2003 | 573 | 0.110 |
Why?
|
| Retrospective Studies | 19 | 2022 | 80673 | 0.110 |
Why?
|
| Organ Size | 1 | 2018 | 2253 | 0.110 |
Why?
|
| Peritoneal Diseases | 1 | 2014 | 75 | 0.110 |
Why?
|
| Pain | 3 | 2015 | 5070 | 0.110 |
Why?
|
| Biomedical Research | 3 | 2018 | 3429 | 0.110 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2018 | 2787 | 0.110 |
Why?
|
| Fetus | 1 | 2020 | 1862 | 0.110 |
Why?
|
| Clinical Trials as Topic | 5 | 2012 | 8000 | 0.100 |
Why?
|
| Ovarian Diseases | 1 | 2014 | 136 | 0.100 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 2019 | 0.100 |
Why?
|
| Risk | 3 | 2014 | 9614 | 0.100 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2014 | 281 | 0.100 |
Why?
|
| Students | 1 | 2022 | 1737 | 0.100 |
Why?
|
| Blood Pressure | 7 | 2019 | 8478 | 0.100 |
Why?
|
| Acute Disease | 5 | 2019 | 7240 | 0.100 |
Why?
|
| Coronary Artery Bypass | 1 | 2001 | 2193 | 0.100 |
Why?
|
| Tetrazoles | 1 | 2018 | 909 | 0.100 |
Why?
|
| Scalp | 1 | 2015 | 389 | 0.100 |
Why?
|
| Heart Rate | 5 | 2015 | 4196 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 11103 | 0.100 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 347 | 0.100 |
Why?
|
| Cadaver | 2 | 2018 | 1358 | 0.100 |
Why?
|
| Brain | 3 | 2016 | 27097 | 0.100 |
Why?
|
| Resistance Training | 1 | 2014 | 192 | 0.100 |
Why?
|
| Single-Blind Method | 3 | 2018 | 1577 | 0.100 |
Why?
|
| Cholesterol, HDL | 3 | 2015 | 1812 | 0.100 |
Why?
|
| Models, Econometric | 3 | 2008 | 215 | 0.100 |
Why?
|
| Anastomosis, Surgical | 1 | 1995 | 982 | 0.100 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 1722 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 1996 | 697 | 0.100 |
Why?
|
| Radiology Information Systems | 1 | 2016 | 529 | 0.100 |
Why?
|
| Reperfusion | 3 | 2020 | 271 | 0.100 |
Why?
|
| Waist-Hip Ratio | 1 | 2012 | 518 | 0.090 |
Why?
|
| Psychotherapy, Group | 1 | 2015 | 413 | 0.090 |
Why?
|
| Occupational Health | 1 | 2018 | 807 | 0.090 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 26068 | 0.090 |
Why?
|
| Hair | 1 | 2015 | 498 | 0.090 |
Why?
|
| Thrombolytic Therapy | 2 | 2019 | 2055 | 0.090 |
Why?
|
| Authorship | 1 | 2014 | 284 | 0.090 |
Why?
|
| Disease-Free Survival | 4 | 2013 | 6817 | 0.090 |
Why?
|
| Multivariate Analysis | 6 | 2015 | 12058 | 0.090 |
Why?
|
| Survival | 1 | 2011 | 161 | 0.090 |
Why?
|
| Disease Progression | 6 | 2018 | 13506 | 0.090 |
Why?
|
| Employment | 2 | 2016 | 1114 | 0.090 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 1990 | 242 | 0.090 |
Why?
|
| Exercise | 2 | 2018 | 5872 | 0.090 |
Why?
|
| Moxibustion | 1 | 2010 | 8 | 0.090 |
Why?
|
| DNA Fingerprinting | 1 | 2010 | 114 | 0.090 |
Why?
|
| Postoperative Complications | 7 | 2015 | 15634 | 0.090 |
Why?
|
| Pharmacogenetics | 1 | 2014 | 675 | 0.090 |
Why?
|
| Version, Fetal | 1 | 2010 | 21 | 0.090 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 1283 | 0.090 |
Why?
|
| Acupuncture Points | 1 | 2010 | 111 | 0.090 |
Why?
|
| Drug Costs | 2 | 2017 | 1183 | 0.080 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2012 | 200 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2018 | 9317 | 0.080 |
Why?
|
| Early Diagnosis | 2 | 2011 | 1187 | 0.080 |
Why?
|
| Health Personnel | 1 | 2023 | 3335 | 0.080 |
Why?
|
| Hospitalization | 3 | 2019 | 10712 | 0.080 |
Why?
|
| Health Surveys | 4 | 2016 | 4036 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2018 | 1126 | 0.080 |
Why?
|
| Diffuse Axonal Injury | 1 | 2009 | 49 | 0.080 |
Why?
|
| Body Constitution | 1 | 2009 | 273 | 0.080 |
Why?
|
| Stochastic Processes | 1 | 2010 | 355 | 0.080 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2013 | 345 | 0.080 |
Why?
|
| Exercise Tolerance | 1 | 2014 | 838 | 0.080 |
Why?
|
| Physicians, Primary Care | 1 | 2016 | 618 | 0.080 |
Why?
|
| Diet, Mediterranean | 1 | 2016 | 738 | 0.080 |
Why?
|
| Renal Veins | 2 | 2008 | 102 | 0.080 |
Why?
|
| Electrocardiography | 4 | 2015 | 6385 | 0.080 |
Why?
|
| Hospitals, University | 2 | 2005 | 566 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2013 | 1223 | 0.080 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2007 | 537 | 0.080 |
Why?
|
| Heart Failure | 3 | 2023 | 11701 | 0.080 |
Why?
|
| Skull Fractures | 2 | 2007 | 202 | 0.080 |
Why?
|
| Incidence | 10 | 2021 | 21357 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 12145 | 0.080 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1990 | 233 | 0.080 |
Why?
|
| Intracranial Hemorrhages | 1 | 2014 | 809 | 0.080 |
Why?
|
| Midwifery | 1 | 2010 | 124 | 0.080 |
Why?
|
| Cerebrovascular Disorders | 2 | 2014 | 1474 | 0.080 |
Why?
|
| Reoperation | 6 | 2014 | 4304 | 0.080 |
Why?
|
| Breast | 1 | 2017 | 1963 | 0.080 |
Why?
|
| Activities of Daily Living | 2 | 2013 | 2420 | 0.070 |
Why?
|
| Aneurysm, Ruptured | 2 | 2014 | 464 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 2632 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 9001 | 0.070 |
Why?
|
| Cardiovascular Agents | 2 | 2013 | 842 | 0.070 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 1738 | 0.070 |
Why?
|
| Nose Neoplasms | 1 | 1990 | 249 | 0.070 |
Why?
|
| Renal Artery | 2 | 2008 | 351 | 0.070 |
Why?
|
| MEDLINE | 1 | 2007 | 119 | 0.070 |
Why?
|
| Counseling | 1 | 2015 | 1536 | 0.070 |
Why?
|
| Nasolacrimal Duct | 1 | 1988 | 79 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 9185 | 0.070 |
Why?
|
| Comorbidity | 6 | 2017 | 10514 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 1921 | 0.070 |
Why?
|
| Carcinoma in Situ | 1 | 2013 | 791 | 0.070 |
Why?
|
| Heterozygote | 1 | 2014 | 2778 | 0.070 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1990 | 290 | 0.070 |
Why?
|
| Communication | 1 | 2001 | 3852 | 0.070 |
Why?
|
| Injury Severity Score | 2 | 2007 | 1045 | 0.070 |
Why?
|
| Lung | 2 | 2019 | 9979 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2015 | 1818 | 0.070 |
Why?
|
| Knee | 1 | 2008 | 279 | 0.070 |
Why?
|
| Publishing | 1 | 2014 | 832 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2016 | 2106 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 1891 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2008 | 366 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1378 | 0.070 |
Why?
|
| Metagenomics | 1 | 2010 | 463 | 0.070 |
Why?
|
| Public Health | 1 | 2020 | 2671 | 0.070 |
Why?
|
| Neoplasms, Second Primary | 1 | 2014 | 1051 | 0.070 |
Why?
|
| Burns | 1 | 2018 | 1875 | 0.070 |
Why?
|
| Value of Life | 2 | 2004 | 98 | 0.070 |
Why?
|
| Collateral Ligaments | 1 | 2006 | 34 | 0.070 |
Why?
|
| Health Behavior | 2 | 2015 | 2641 | 0.070 |
Why?
|
| Databases, Factual | 3 | 2018 | 7969 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 2 | 2020 | 462 | 0.070 |
Why?
|
| Lacrimal Apparatus | 1 | 1988 | 223 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 591 | 0.070 |
Why?
|
| Hippocampus | 1 | 2018 | 3757 | 0.060 |
Why?
|
| Professional Competence | 1 | 2009 | 430 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 299 | 0.060 |
Why?
|
| Bone and Bones | 2 | 2007 | 2567 | 0.060 |
Why?
|
| Health | 1 | 2008 | 398 | 0.060 |
Why?
|
| Endometriosis | 1 | 2014 | 857 | 0.060 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2706 | 0.060 |
Why?
|
| Paranasal Sinuses | 1 | 1988 | 265 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2013 | 6482 | 0.060 |
Why?
|
| Liver | 2 | 2018 | 7513 | 0.060 |
Why?
|
| Motivation | 1 | 2015 | 2003 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2013 | 1084 | 0.060 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 493 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5667 | 0.060 |
Why?
|
| Immunization Programs | 1 | 2008 | 267 | 0.060 |
Why?
|
| Ankle | 1 | 2008 | 350 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2013 | 1725 | 0.060 |
Why?
|
| Colonoscopy | 2 | 2010 | 1398 | 0.060 |
Why?
|
| Colonic Polyps | 1 | 2010 | 553 | 0.060 |
Why?
|
| Propensity Score | 1 | 2012 | 1913 | 0.060 |
Why?
|
| Coronary Restenosis | 1 | 2007 | 396 | 0.060 |
Why?
|
| Publication Bias | 2 | 2016 | 160 | 0.060 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 951 | 0.060 |
Why?
|
| Iohexol | 1 | 2005 | 205 | 0.060 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2010 | 558 | 0.060 |
Why?
|
| Linear Models | 3 | 2006 | 5869 | 0.060 |
Why?
|
| Hemostasis | 1 | 2007 | 470 | 0.060 |
Why?
|
| Tibial Fractures | 1 | 2007 | 272 | 0.060 |
Why?
|
| Length of Stay | 3 | 2009 | 6420 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 1 | 2010 | 934 | 0.060 |
Why?
|
| Pandemics | 1 | 2024 | 8663 | 0.060 |
Why?
|
| Gynecology | 1 | 2010 | 526 | 0.060 |
Why?
|
| Aortography | 3 | 2009 | 421 | 0.060 |
Why?
|
| Cholesterol | 3 | 2014 | 2902 | 0.060 |
Why?
|
| Femoral Fractures | 1 | 2007 | 375 | 0.060 |
Why?
|
| Systole | 1 | 2005 | 936 | 0.050 |
Why?
|
| Ultrasonography | 4 | 2020 | 5971 | 0.050 |
Why?
|
| Affect | 1 | 2011 | 1486 | 0.050 |
Why?
|
| Policy Making | 1 | 2007 | 541 | 0.050 |
Why?
|
| Societies, Scientific | 1 | 2004 | 223 | 0.050 |
Why?
|
| Critical Care | 1 | 2016 | 2690 | 0.050 |
Why?
|
| Hospitals, Community | 1 | 2005 | 365 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3770 | 0.050 |
Why?
|
| Academic Medical Centers | 3 | 2018 | 2757 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2009 | 1198 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2009 | 1834 | 0.050 |
Why?
|
| Anesthesia | 1 | 2013 | 1591 | 0.050 |
Why?
|
| Lipids | 1 | 2012 | 3330 | 0.050 |
Why?
|
| Intracranial Embolism | 1 | 2003 | 189 | 0.050 |
Why?
|
| Health Education | 2 | 1999 | 1049 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2005 | 633 | 0.050 |
Why?
|
| Logic | 1 | 2001 | 40 | 0.050 |
Why?
|
| Hemodynamics | 3 | 2006 | 4164 | 0.050 |
Why?
|
| Albumins | 1 | 2024 | 575 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2007 | 1436 | 0.050 |
Why?
|
| Stroke Volume | 2 | 2012 | 5520 | 0.050 |
Why?
|
| Consensus | 1 | 2011 | 3133 | 0.050 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 1004 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2013 | 5103 | 0.050 |
Why?
|
| Cesarean Section | 1 | 2010 | 1396 | 0.050 |
Why?
|
| Hypoglycemic Agents | 2 | 2024 | 3086 | 0.050 |
Why?
|
| Pregnancy | 3 | 2020 | 29872 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2016 | 4795 | 0.040 |
Why?
|
| Graft Survival | 1 | 2011 | 3841 | 0.040 |
Why?
|
| Neurosurgical Procedures | 2 | 2008 | 2067 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 4251 | 0.040 |
Why?
|
| Food, Fortified | 1 | 2001 | 189 | 0.040 |
Why?
|
| Epidemiologic Methods | 2 | 2020 | 1336 | 0.040 |
Why?
|
| Genotype | 1 | 2014 | 12983 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 1419 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2003 | 557 | 0.040 |
Why?
|
| Reference Standards | 2 | 2018 | 1005 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2010 | 2687 | 0.040 |
Why?
|
| Educational Status | 3 | 2019 | 2510 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2014 | 4060 | 0.040 |
Why?
|
| Sex Distribution | 3 | 2010 | 2278 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 2025 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2010 | 2642 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2018 | 42217 | 0.040 |
Why?
|
| Cervical Vertebrae | 1 | 2005 | 976 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2023 | 2112 | 0.040 |
Why?
|
| Intracranial Aneurysm | 1 | 2008 | 1286 | 0.040 |
Why?
|
| Hospitals, Special | 1 | 2019 | 91 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2007 | 1546 | 0.040 |
Why?
|
| Registries | 3 | 2015 | 8236 | 0.040 |
Why?
|
| Spinal Fractures | 1 | 2005 | 704 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2001 | 524 | 0.040 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2019 | 97 | 0.040 |
Why?
|
| Simvastatin | 2 | 2017 | 346 | 0.040 |
Why?
|
| Homocysteine | 1 | 2001 | 637 | 0.040 |
Why?
|
| Thinking | 1 | 2001 | 319 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2003 | 981 | 0.040 |
Why?
|
| Patient Simulation | 1 | 2000 | 297 | 0.040 |
Why?
|
| Intracranial Thrombosis | 1 | 2019 | 108 | 0.040 |
Why?
|
| Diet | 1 | 2016 | 8047 | 0.040 |
Why?
|
| Transportation of Patients | 1 | 2019 | 174 | 0.040 |
Why?
|
| Electronic Mail | 1 | 2019 | 213 | 0.040 |
Why?
|
| Catheterization, Peripheral | 1 | 2001 | 343 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2008 | 1658 | 0.040 |
Why?
|
| Random Allocation | 1 | 2002 | 2393 | 0.040 |
Why?
|
| Myocardial Revascularization | 2 | 2012 | 794 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2006 | 1796 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 1663 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2002 | 730 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 4673 | 0.030 |
Why?
|
| Amlodipine | 1 | 2017 | 84 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2003 | 1165 | 0.030 |
Why?
|
| Hydrochlorothiazide | 1 | 2017 | 94 | 0.030 |
Why?
|
| Calibration | 2 | 2011 | 819 | 0.030 |
Why?
|
| Tablets | 1 | 2017 | 148 | 0.030 |
Why?
|
| Japan | 1 | 2021 | 1373 | 0.030 |
Why?
|
| Third-Party Consent | 1 | 2016 | 66 | 0.030 |
Why?
|
| Mortality | 2 | 2018 | 2896 | 0.030 |
Why?
|
| Patient Care Management | 1 | 2019 | 302 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2011 | 3627 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 908 | 0.030 |
Why?
|
| Carotid Artery, Internal | 2 | 2002 | 445 | 0.030 |
Why?
|
| Hemostatic Techniques | 1 | 1996 | 111 | 0.030 |
Why?
|
| Losartan | 1 | 2017 | 263 | 0.030 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 1995 | 85 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2000 | 1242 | 0.030 |
Why?
|
| Punctures | 1 | 1996 | 366 | 0.030 |
Why?
|
| Depression | 1 | 2014 | 8130 | 0.030 |
Why?
|
| Respiratory Rate | 1 | 2015 | 176 | 0.030 |
Why?
|
| Folic Acid | 1 | 2001 | 1323 | 0.030 |
Why?
|
| Basilar Artery | 1 | 2015 | 205 | 0.030 |
Why?
|
| Unemployment | 1 | 2016 | 210 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 3707 | 0.030 |
Why?
|
| Hemostatics | 1 | 1996 | 240 | 0.030 |
Why?
|
| Confidentiality | 1 | 2018 | 607 | 0.030 |
Why?
|
| Behavior | 1 | 2016 | 540 | 0.030 |
Why?
|
| Regional Health Planning | 1 | 1994 | 96 | 0.030 |
Why?
|
| Vibration | 1 | 2015 | 328 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2081 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2019 | 1162 | 0.030 |
Why?
|
| Resuscitation | 1 | 2017 | 672 | 0.030 |
Why?
|
| Child | 4 | 2019 | 80134 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2000 | 968 | 0.030 |
Why?
|
| Hypertension, Renovascular | 2 | 2004 | 115 | 0.030 |
Why?
|
| Choice Behavior | 1 | 1998 | 824 | 0.030 |
Why?
|
| Weight Loss | 1 | 2024 | 2680 | 0.030 |
Why?
|
| Cats | 1 | 2013 | 974 | 0.030 |
Why?
|
| South Africa | 1 | 2018 | 1843 | 0.030 |
Why?
|
| Vascular Grafting | 1 | 2014 | 162 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2016 | 549 | 0.020 |
Why?
|
| Boston | 2 | 2016 | 9324 | 0.020 |
Why?
|
| Hearing Loss | 1 | 2019 | 782 | 0.020 |
Why?
|
| Binomial Distribution | 1 | 1991 | 23 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2009 | 22157 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 1995 | 1097 | 0.020 |
Why?
|
| Patient Transfer | 1 | 2019 | 793 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2014 | 284 | 0.020 |
Why?
|
| Preoperative Care | 3 | 2013 | 2242 | 0.020 |
Why?
|
| Workplace | 1 | 2018 | 864 | 0.020 |
Why?
|
| Peer Review, Research | 1 | 2014 | 339 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2018 | 26187 | 0.020 |
Why?
|
| Urban Population | 1 | 2019 | 2035 | 0.020 |
Why?
|
| Nuclear Medicine | 1 | 2014 | 257 | 0.020 |
Why?
|
| Fetal Organ Maturity | 1 | 1990 | 83 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2017 | 2048 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2016 | 818 | 0.020 |
Why?
|
| Aspirin | 1 | 2002 | 3128 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 4908 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2015 | 765 | 0.020 |
Why?
|
| Bibliometrics | 1 | 2014 | 352 | 0.020 |
Why?
|
| Myocardium | 1 | 2003 | 4746 | 0.020 |
Why?
|
| Norway | 1 | 2011 | 499 | 0.020 |
Why?
|
| General Practice | 1 | 2011 | 97 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2013 | 518 | 0.020 |
Why?
|
| Endarterectomy | 1 | 2010 | 196 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2002 | 3923 | 0.020 |
Why?
|
| Early Detection of Cancer | 2 | 2014 | 3196 | 0.020 |
Why?
|
| Glomus Tumor | 1 | 1990 | 62 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 30006 | 0.020 |
Why?
|
| Barium Sulfate | 1 | 2009 | 180 | 0.020 |
Why?
|
| Specialization | 1 | 2014 | 778 | 0.020 |
Why?
|
| Physicians | 2 | 2018 | 4583 | 0.020 |
Why?
|
| Sigmoidoscopy | 1 | 2009 | 151 | 0.020 |
Why?
|
| Electronic Health Records | 2 | 2016 | 4813 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2009 | 5879 | 0.020 |
Why?
|
| Neoplasms | 2 | 2016 | 22125 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 4014 | 0.020 |
Why?
|
| Adenosine | 1 | 2013 | 805 | 0.020 |
Why?
|
| Body Weight | 1 | 2019 | 4618 | 0.020 |
Why?
|
| Survivors | 2 | 2014 | 2369 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2001 | 3410 | 0.020 |
Why?
|
| Health Expenditures | 1 | 2021 | 2363 | 0.020 |
Why?
|
| Rural Population | 1 | 2019 | 2277 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2218 | 0.020 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2009 | 170 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2001 | 3238 | 0.020 |
Why?
|
| Collagen | 1 | 1996 | 2635 | 0.020 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 1988 | 53 | 0.020 |
Why?
|
| Renal Circulation | 1 | 2008 | 291 | 0.020 |
Why?
|
| Laparoscopy | 2 | 2014 | 2030 | 0.020 |
Why?
|
| Data Collection | 1 | 1997 | 3319 | 0.020 |
Why?
|
| Health Services Research | 1 | 1995 | 1807 | 0.020 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 1990 | 262 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2007 | 223 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 1992 | 648 | 0.020 |
Why?
|
| Carotid Artery, Common | 1 | 2008 | 175 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2008 | 320 | 0.020 |
Why?
|
| Social Support | 1 | 2016 | 2175 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 2011 | 492 | 0.020 |
Why?
|
| Hospitals | 1 | 2019 | 3881 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2014 | 1966 | 0.020 |
Why?
|
| Family | 1 | 2016 | 3193 | 0.020 |
Why?
|
| Recurrence | 1 | 1998 | 8456 | 0.020 |
Why?
|
| Infant | 2 | 2018 | 36164 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 846 | 0.020 |
Why?
|
| Wound Healing | 2 | 2006 | 2801 | 0.010 |
Why?
|
| Rupture | 1 | 2006 | 443 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2004 | 181 | 0.010 |
Why?
|
| Internationality | 1 | 2010 | 1000 | 0.010 |
Why?
|
| Radionuclide Ventriculography | 1 | 2003 | 40 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2017 | 3743 | 0.010 |
Why?
|
| Morals | 1 | 2007 | 289 | 0.010 |
Why?
|
| Dipyridamole | 1 | 2003 | 142 | 0.010 |
Why?
|
| Research | 2 | 2007 | 1975 | 0.010 |
Why?
|
| Posture | 1 | 2008 | 956 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2011 | 2327 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1996 | 1624 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 6857 | 0.010 |
Why?
|
| Critical Illness | 1 | 2016 | 2709 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2009 | 982 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1301 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 787 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2009 | 1315 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2009 | 1251 | 0.010 |
Why?
|
| Primary Health Care | 1 | 1998 | 4673 | 0.010 |
Why?
|
| Gestational Age | 1 | 1990 | 3577 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2003 | 577 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2010 | 2247 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 2692 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2003 | 540 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2008 | 2913 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3509 | 0.010 |
Why?
|
| Attention | 1 | 2009 | 2394 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2009 | 2599 | 0.010 |
Why?
|
| Pravastatin | 1 | 2000 | 392 | 0.010 |
Why?
|
| History, 21st Century | 1 | 2004 | 1566 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5249 | 0.010 |
Why?
|
| Nerve Net | 1 | 2009 | 2290 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 7804 | 0.010 |
Why?
|
| Social Values | 1 | 1998 | 225 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 7043 | 0.010 |
Why?
|
| Dopamine | 1 | 2003 | 1606 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2004 | 2764 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2009 | 3974 | 0.010 |
Why?
|
| Health Policy | 1 | 2007 | 2680 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2001 | 1724 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1990 | 4021 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2009 | 6635 | 0.010 |
Why?
|
| Aneurysm, False | 1 | 1996 | 255 | 0.010 |
Why?
|
| Pressure | 1 | 1996 | 1152 | 0.010 |
Why?
|
| Arteriovenous Fistula | 1 | 1996 | 319 | 0.010 |
Why?
|
| Social Environment | 1 | 1998 | 1021 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1990 | 6340 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 6305 | 0.010 |
Why?
|
| Safety | 1 | 1996 | 1151 | 0.010 |
Why?
|
| Fibrinolytic Agents | 1 | 2001 | 2075 | 0.010 |
Why?
|
| HIV Infections | 1 | 1998 | 17349 | 0.010 |
Why?
|
| Hematoma | 1 | 1996 | 763 | 0.010 |
Why?
|
| Arteries | 1 | 1996 | 1121 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 168083 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 12975 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1996 | 1303 | 0.010 |
Why?
|
| Obesity | 1 | 2009 | 12937 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 1995 | 4319 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1992 | 12341 | 0.000 |
Why?
|